Kristi Baum-Skorija, MBA

Kristi Baum-Skorija, MBA, is an Executive Director who leads reimbursement strategy projects within Fortrea’s Market Access Consulting and HEOR group. She has more than 15 years of experience conducting market access assessments, developing provider-facing economic models, and delivering reimbursement trainings. She has led numerous initiatives supporting pharmaceutical, biotech, diagnostic, and medical devices, with deep experience in coding, coverage, and payment policy. She also has extensive experience conducting in-depth qualitative interviews with key reimbursement decision-makers and clinical experts across settings of care.

Before joining Fortrea (formerly Labcorp and Covance), Kristi worked in a laboratory setting, conducting endocrine-related scientific research and cardiovascular pathology assessments for medical devices and other cardiovascular therapies.  

Kristi earned an MBA from the MIT Sloan School of Management and a BS in Biology from Oakland University. During her time at Sloan, she focused on healthcare management and data analysis, with a special interest in strategy and market analysis.